Vetter Pioneers Market Launch of Eight Innovative Drug Products in 2023

Vetter, a globally recognized contract development and manufacturing organization (CDMO), proudly announces the successful market introduction of eight cus...

February 14, 2024 | Wednesday | News
Exscientia Dismisses CEO Andrew Hopkins Over Inappropriate Relationships

Exscientia plc (Nasdaq: EXAI), a frontrunner in AI-driven precision medicine, has officially announced a significant leadership adjustment and the submissi...

February 14, 2024 | Wednesday | News
Roche Collaborates with PathAI to Enhance Digital Pathology Capabilities for Companion Diagnostics

PathAI will exclusively work with Roche Tissue Diagnostics (RTD) to develop artificial intelligence (AI) digital pathology algorithms for RTD's companion...

February 13, 2024 | Tuesday | News
Curasight Announces Accelerated Basket Trial Targeting Five Cancer Indications

Curasight A/S ("Curasight" or the "Company" (XSAT: CURAS) is forging ahead with its mission to revolutionize cancer treatment, announcing today the acceler...

February 13, 2024 | Tuesday | News
Biovian and 3P Biopharmaceuticals Form 3PBIOVIAN, a Pan-European Biologics Powerhouse

Backed by their common shareholder, Keensight Capital, one of the leading private equity funds dedicated to pan-European Growth Buyout[] investments, the c...

February 02, 2024 | Friday | News
Carcinotech Secures $5.3M Funding to Boost Global Expansion of Carcino3D Technology

Carcinotech has raised $5.3 million of funding as the company looks to build on its traction in the UK and Europe, with US expansion planned later this yea...

January 31, 2024 | Wednesday | News
Sandoz Introduces Tyruko® Biosimilar for MS, a Milestone in Germany

Tyruko® approved for all indications of reference medicine  Tyruko® biosimilar to treat adults with highly active relapsing remitting multi...

January 31, 2024 | Wednesday | News
Qubit Pharma, Institut Curie, and University of Bordeaux Collaborate on Innovative Cancer Therapies

The three partners are joining forces to develop drug candidates that modulate the immune response of cancer patients and block the development of metast...

January 30, 2024 | Tuesday | News
RevoluGen and LGC Biosearch Showcase Advanced DNA Extraction with Fire Monkey Chemistry

Under a collaboration with LGC Biosearch TechnologiesTM, RevoluGen has coupled its Fire Monkey chemistry with LGC magnetic beads and LGC oKtopureTM liquid ...

January 30, 2024 | Tuesday | News
German Company FUSE-AI Launches Groundbreaking AI Algorithm for Radiology to the Market

Prostate.Carcinoma.ai“ significantly aids radiologists by automatically segmenting the prostate gland in MRI scans and independently identifying path...

January 29, 2024 | Monday | News
STARLIMS Launches Next-Gen LIMS, Life Sciences for Public Health (LPH) 1.0

Embracing the latest technology trends, LPH 1.0 represents a significant leap forward, with an upgrade to HTML5 browser-based technology. This advancement ...

January 23, 2024 | Tuesday | News
Vivtex Enters Research Collaboration with Astellas Pharma

Maureen Deehan, CEO of Vivtex, commented: “We are delighted to enter this new collaboration with Astellas Pharma. Over the past few years, Vivtex has...

January 23, 2024 | Tuesday | News
SGD Pharma Boosts Siliconized Glass Vial Capacity with New Line in France

Glass vials are regularly used for pharmaceutical packaging, though there is a growing market need for primary packaging that is suited to more sensitive, ...

January 22, 2024 | Monday | News
Thermo Fisher's Monza Facility Gains AIFA Approval for RNA Drug Production

Thermo Fisher Scientific, the world leader in the service of science, has received Good Manufacturing Practice (GMP) approval from the Italian Medicines Ag...

January 19, 2024 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close